Akari Therapeutics (AKTX) Non-cash Items (2014 - 2020)

Akari Therapeutics (AKTX) has reported Non-cash Items for 5 consecutive years, with $2.6 million the latest figure, recorded in Q4 2020.

• Quarterly Non-cash Items fell 40.98% year-over-year to $2.6 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $131209.0 (down 96.66% YoY) and the FY2021 annual result came in at -$1.4 million, down 1183.99% from the prior year.
• Non-cash Items advanced to $2.6 million in Q4 2020 per AKTX's latest filing, from -$1.6 million in the prior quarter.
• Over the last five years, Non-cash Items for AKTX reached as high as $4.4 million in Q4 2019 and fell as low as -$4.5 million in Q1 2016.
• A 3-year average of $36384.7 and a median of $587697.5 in 2016 frame the typical range for Non-cash Items.
• Annual changes were most pronounced in 2016 — Non-cash Items tumbled 1427.36% — and 2020, when it jumped 169.42%.
• Year by year, Non-cash Items stood at $759940.0 in 2016, then surged by 474.48% to $4.4 million in 2019, then sank by 40.98% to $2.6 million in 2020.
• According to Business Quant data, Non-cash Items over the past three periods registered $2.6 million, -$1.6 million, and $3.2 million for Q4 2020, Q3 2020, and Q2 2020 respectively.